Catalyst Biosciences hematology news

Catalyst will reduce headcount by 10 (50%) to about 10 to focus resources on its hemostasis programs, primarily CB 813d and CB 2679d

Read the full 234 word article

How to gain access

Continue reading with a
two-week free trial.